Amaero Ltd has obtained Federal Court approval to re-domicile to Delaware via schemes exchanging Australian shares and options for US HoldCo equivalents, marking a major structural shift.
- Federal Court approves schemes of arrangement
- Amaero US HoldCo to become new parent company
- ASX trading of Amaero shares ends 11 June 2026
- US HoldCo CDIs begin deferred trading 12 June 2026
- Normal ASX trading of US HoldCo CDIs from 23 June 2026
Federal Court Greenlights Re-domiciliation
Amaero Ltd (ASX:3DA) has cleared a significant legal hurdle, with the Federal Court of Australia granting approval for the company’s schemes of arrangement that underpin its re-domiciliation to the United States. The approved Share Scheme and Option Scheme pave the way for Amaero US HoldCo to acquire 100% of Amaero’s issued shares, effectively making the US entity the new ultimate parent of the Amaero Group.
This approval formalises the exchange of existing Amaero shares and options for securities in Amaero US HoldCo, a Delaware-registered holding company. The move signals a strategic shift aimed at aligning the company’s corporate structure with its operational base and growth ambitions in the US advanced manufacturing sector.
Trading Transition and Timetable
The schemes will become legally effective upon lodgment of the Court orders with the Australian Securities and Investments Commission on 11 June 2026. This date also marks the final day Amaero shares will trade on the ASX.
From 12 June, holders will see Amaero US HoldCo CHESS Depositary Interests (CDIs) commence trading on the ASX on a deferred settlement basis, transitioning to normal T+2 settlement trading from 23 June. The official implementation of the schemes is scheduled for 22 June, with holding statements for the new securities dispatched in the following days.
The staggered timetable accommodates time zone differences and regulatory processes, reflecting the complexity of cross-border corporate restructures. Shareholders and option holders will need to monitor these key dates closely to manage their positions.
Operational Focus Remains on Advanced Manufacturing
While the re-domiciliation restructures Amaero’s corporate domicile, the company will continue its operations from Tennessee, US, where it specialises in producing high-value refractory and titanium alloy powders. These materials serve critical sectors including defence, aerospace, aviation, and medical industries.
Amaero’s expertise in gas atomization technology and powder metallurgy hot isostatic pressing (PM-HIP) positions it as a key player in addressing domestic supply chain constraints for large-scale castings and forgings. The re-domiciliation could position Amaero to tap deeper into US capital markets and strategic growth opportunities, although the filing does not provide financial guidance or detail on operational impacts.
Legal and Regulatory Considerations
The announcement underscores the procedural nature of the re-domiciliation, with all actions subject to regulatory approvals and conditions precedent. Amaero cautions that the timetable may shift due to factors beyond its control, including the Court’s processes.
The company also reiterates standard disclaimers regarding forward-looking statements and investment advice, reflecting the inherent uncertainties in corporate restructures of this scale.
Bottom Line?
Amaero’s court-approved re-domiciliation is a pivotal step in aligning its corporate structure with US operations, but investors should watch the transition timetable and regulatory developments closely.
Questions in the middle?
- How will the re-domiciliation impact Amaero’s access to US capital markets?
- What are the potential tax and regulatory implications for shareholders post-re-domiciliation?
- Will the structural change influence Amaero’s strategic partnerships or contract opportunities?